US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery Jan 2, 2024 Posted by suite1000 In People About the author ⁄ suite1000 Prev Harvard president Claudine Gay resigns amid plagiarism claims, backlash from antisemitism testimony Next Short-term leases from 5 to 12 months are increasingly popular
